Vol. I · No. 33
Thursday, August 13, 2026
Issue: Summer · 2026
Established · MMXXVI
— The evidence base for longevity medicine —
Indexed by PubMed · CTG · Cochrane
Editorial team · geroevidence.com
Subscription · app.geroevidence.com

The LIFE study: what the largest exercise trial in older adults found

LIFE (Lifestyle Interventions and Independence for Elders) is the most rigorous RCT of physical activity in older adults at risk of mobility disability.

By Geroevidence editorial team·Published 19 July 2026·Category clinical trials·10 min read
§ Overview

LIFE (Lifestyle Interventions and Independence for Elders) is the most rigorous RCT of physical activity in older adults at risk of mobility disability.

Evidence tier: Strong. Drug class: Physical activity intervention. This profile synthesizes the published human trial evidence. The full profile with all indexed papers, active trial alerts, and tier history is available to subscribers.

§ Key human evidence
RCT
LIFE Study Investigators — JAMA, 2014
n=1,635
Sedentary adults 70–89 years at risk for mobility disability. Structured physical activity program (150 min/week moderate intensity walking + strength/balance exercises) versus health education control for 2.6 years. Primary endpoint: major mobility disability. Relative risk reduction 18% (HR 0.82, 95% CI 0.69–0.98). Statistically significant. The only RCT of exercise to show significant hard physical function endpoint in this population.
Extended follow-up
LIFE extension — Annals of Internal Medicine, 2017
n=1,635
Extended follow-up of LIFE participants. Physical activity arm continued to show benefit in preventing persistent mobility disability (HR 0.75, p=0.03) even after formal trial ended. Benefit persisted up to 4 years from randomization. Important for durability of exercise intervention effects.
Cost-effectiveness
LIFE cost-effectiveness analysis — JAMA, 2017
n=1,635
Physical activity intervention was cost-effective at standard thresholds ($28,170/QALY gained). Compares favorably to most pharmaceutical interventions in preventive medicine. Strong policy-relevant finding for exercise prescription in older adults.
§ The honest clinical position

Every Geroevidence profile ends with an honest assessment of what the evidence supports and what it does not. This intervention is rated Strong based on the published human trial evidence indexed above.

The full honest clinical assessment — including evidence tier rationale, key limitations, and what trials would be needed to upgrade the tier — is in the subscriber profile. The summary: the mechanistic basis is coherent and human trial data is available; the specific clinical applications and limitations are detailed in the full profile.

This information is provided for educational reference only and does not constitute medical advice or a treatment recommendation.

Full evidence profile
All indexed papers · active trials · daily alerts
Start free trial
14 DAYS FREE · NO CARD REQUIRED
Top interventions by evidence
GLP-1 agonists
CV outcome trials · SELECT
Strong
SGLT2 inhibitors
EMPA-REG · DECLARE
Strong
Rapamycin
mTOR inhibitor · PEARL
Moderate
View all interventions →